Calcium Sulfate

• Uses For the temporary relief of symptoms associated with skin irritation tender gums Directions Tip bottle slightly allowing for tablets to fall into the cap. Use cap to drop tablets into mouth and allow them to dissolve under the tongue.

Directions Tip bottle slightly allowing for tablets to fall into the cap. Use cap to drop tablets into mouth and allow them to dissolve under the tongue. Adults and adolescents (12 years and older) Take 1 to 4 tablets, one to four times daily, or as recommended by your healthcare practitioner. Children (under 12 years) Take under the direction of your healthcare practitioner.

Do not use if you ever had an allergic reaction to this product or any of its ingredients. Stop use and ask a doctor if symptoms persist or worsen. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

1. 1Diarrhoea346.2%
2. 2Pain346.2%
3. 3Headache336.0%
4. 4Fatigue305.5%
5. 5Nausea305.5%
6. 6Arthralgia274.9%
7. 7Dizziness264.7%
8. 8Pain In Extremity234.2%
9. 9Asthenia203.6%
10. 10Drug Ineffective203.6%
11. 11Abdominal Pain Upper193.5%
12. 12Dyspnoea193.5%
13. 13Fall193.5%
14. 14Gait Disturbance183.3%
15. 15Muscle Spasms183.3%

Recent PubMed references pinned to Calcium Sulfate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Tracking the current situation and key paths of phosphogypsum harmlessness.
  Journal of environmental sciences (China) · 2026 · Zou H, Chen Z, Jiang J, et al.
  PMID 42217903DOI 10.1016/j.jes.2025.10.007
• Molecular-level interaction mechanisms of humic acid and residual aluminum species in gypsum scaling during nanofiltration.
  Water research · 2026 · Jia J, Zhang X, Lin D, et al.
  PMID 42208184DOI 10.1016/j.watres.2026.126126
• Mobility and environmental risk of potentially toxic elements (PTEs) in phosphogypsum-amended saline soils: an integrated soil-leachate assessment.
  Environmental geochemistry and health · 2026 · Mezlini W, Limonti C, Siciliano A, et al.
  PMID 42171794DOI 10.1007/s10653-026-03250-4
• Bioprocess-based recycling of phosphogypsum for sustainable product development.
  Journal of environmental management · 2026 · Chernysh Y, Chubur V, Ostroha R, et al.
  PMID 42160856DOI 10.1016/j.jenvman.2026.129998
• Surface-functionalized microcrystalline cellulose derived from quinoa stalks as a sustainable reinforcing additive for phosphogypsum-based cement composite.
  International journal of biological macromolecules · 2026 · Sina AT, Laabid A, Belasri A, et al.
  PMID 42067088DOI 10.1016/j.ijbiomac.2026.152297
• Mesoscopic insights into the mitigation of gypsum scaling during nanofiltration by salinity and natural organic matter for drinking water treatment.
  Water research · 2026 · Ji P, Chang H
  PMID 42056798DOI 10.1016/j.watres.2026.125991
• In-situ remediation of phosphogypsum stockpiles via Ca-based immobilization: leaching behavior and groundwater protection.
  Environmental geochemistry and health · 2026 · Zixiang C, Qutian Z, Xia Z, et al.
  PMID 42035392DOI 10.1007/s10653-026-03206-8
• Water resistance degradation and sulfate leaching behavior in phosphogypsum-based composite concrete: Simulation, mechanisms and coupling effects.
  Journal of environmental management · 2026 · Wang X, Qin X, Zhu S, et al.
  PMID 42034360DOI 10.1016/j.jenvman.2026.129753

The 10 most recently updated of 267 ClinicalTrials.gov registrations naming Calcium Sulfate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
  Recruiting · Phase 2 · Interventional · 461 enrolled · National Cancer Institute (NCI)
  NCT04546399updated 2026-06-12
• Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
  Active not recruiting · Phase 3 · Interventional · 67 enrolled · Calcilytix Therapeutics, Inc., a BridgeBio company
  NCT05680818updated 2026-06-11
• Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma
  Active not recruiting · Phase 3 · Interventional · 847 enrolled · National Cancer Institute (NCI)
  NCT02112916updated 2026-06-03
• Empiric Versus Selective Prevention Strategies for Kidney Stone Disease
  Completed · Phase 4 · Interventional · 56 enrolled · Vanderbilt University Medical Center
  NCT05365477updated 2026-06-03
• Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
  Active not recruiting · Phase 3 · Interventional · 669 enrolled · National Cancer Institute (NCI)
  NCT02101853updated 2026-06-03
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
  Completed · Phase 3 · Interventional · 5,949 enrolled · National Cancer Institute (NCI)
  NCT02883049updated 2026-06-02
• Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
  Active not recruiting · Phase 2 · Interventional · 97 enrolled · National Cancer Institute (NCI)
  NCT00792948updated 2026-05-29
• Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
  Active not recruiting · Phase 3 · Interventional · 488 enrolled · National Cancer Institute (NCI)
  NCT02003222updated 2026-05-28
• Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
  Completed · Phase 3 · Interventional · 9,350 enrolled · Children's Oncology Group
  NCT01190930updated 2026-05-28
• A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia
  Active not recruiting · Phase 3 · Interventional · 6,720 enrolled · National Cancer Institute (NCI)
  NCT03914625updated 2026-05-27

Frequently asked questions

What is Calcium Sulfate used for?

According to FDA labeling, Calcium Sulfate carries indications including: Uses For the temporary relief of symptoms associated with skin irritation tender gums Directions Tip bottle slightly allowing for tablets to fall into the cap. Use cap to drop tablets into mouth and allow them to dissolve under the tongue.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.